With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.34946-82-2,Copper(II) trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
For the synthesis of (I), a solution of BDPA (0.160 g,0.554 mmol) in THF (6.0 ml) was added to a solution of Cu(triflate)2 (0.200 g, 0.554 mmol) in THF (6.0 ml) and theresulting mixture was stirred for 12 h. The resulting palegreen-palegreen-blue solution was concentrated under reduced pressure,affording a pale-green-blue solid which was dried under high vacuum. The solid was dissolved in THF and diffused withdiethyl ether, giving blue block-shaped crystals after 5 d(yield: 0.102 g, 26%). Elemental analysis calculated: C 40.51,H 3.94, N 5.67, S 8.65%; found: C 40.31, H 3.79, N 5.62; S8.69%. FT-IR (KBr, cm-1); 3374 (m), 3092 (w), 3030 (w), 2965(w), 2969 (m), 2880 (w), 1657 (m), 1612 (s), 1484 (m), 1450 (s),1358 (w), 1288 (s), 1250 (s), 1168 (s), 1030 (s), 860 (m), 771(m), 706 (m), 635 (s).
34946-82-2 Copper(II) trifluoromethanesulfonate 2734996, acopper-catalyst compound, is more and more widely used in various.
Reference£º
Article; Sivanesan, Dharmalingam; Youn, Min Hye; Park, Ki Tae; Kim, Hak Joo; Grace, Andrews Nirmala; Jeong, Soon Kwan; Acta Crystallographica Section C: Structural Chemistry; vol. 73; 11; (2017); p. 1024 – 1029;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”